e-learning
resources
Vienna 2009
Monday, 14.09.2009
New treatment and outcome measures for pulmonary rehabilitation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effects of pulmonary rehabilitation in patients with interstitial lung disease (ILD)
U. Kaufmann, M. Bönsch, M. Studnicka, K. Kenn (Schönau am Königssee, Germany; Salzburg, Austria)
Source:
Annual Congress 2009 - New treatment and outcome measures for pulmonary rehabilitation
Session:
New treatment and outcome measures for pulmonary rehabilitation
Session type:
E-Communication Session
Number:
1712
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
U. Kaufmann, M. Bönsch, M. Studnicka, K. Kenn (Schönau am Königssee, Germany; Salzburg, Austria). Effects of pulmonary rehabilitation in patients with interstitial lung disease (ILD). Eur Respir J 2009; 34: Suppl. 53, 1712
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Related content which might interest you:
Effects of pulmonary rehabilitation in patients with severe COPD in comparison to patients with severe interstitial lung disease
Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation
Year: 2013
Pulmonary rehabilitation (PR) outcomes in chronic obstructive pulmonary disease (COPD) compared with interstitial lung disease (ILD)
Source: Annual Congress 2011 - Pulmonary rehabilitation: looking at alternative approaches and alternative populations beyond COPD
Year: 2011
Efficacy of pulmonary rehabilitation in patients with interstitial lung disease
Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care
Year: 2012
Pulmonary rehabilitation (PR) exercise tolerance improvement: Differences between interstitial lung disease (ILD) and chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in different chronic conditions
Year: 2013
Benefits of pulmonary rehabilitation (PR) in patients with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) having the same dyspnoea severity
Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)?
Year: 2018
Patients profile and pulmonary rehabilitation in interstitial lung disease
Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care
Year: 2018
Effects of inpatient pulmonary rehabilitation in patients with interstitial lung disease
Source: Eur Respir J 2013; 42: 444-453
Year: 2013
Effects of a 6-months comprehensive pulmonary rehabilitation program (CPRP) in patients with diffuse interstitial lung diseases (ILD)
Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases
Year: 2019
Effects of a combination of pulmonary rehabilitation (PR) and non invasive ventilation (NIV) in patients with advanced interstitial lung disease (ILD)
Source: Annual Congress 2009 - Noninvasive ventilation in chronic respiratory failure
Year: 2009
Benefit of treatment with pirfenidone (PFD) persists over time in patients with idiopathic pulmonary fibrosis (IPF) with limited lung function impairment
Source: International Congress 2016 – IPF treatment I
Year: 2016
Functional status following pulmonary rehabilitation in patients with interstitial lung disease
Source: Virtual Congress 2021 – Peripheral muscle function, exercise capacity and functional status in respiratory disease
Year: 2021
Pulmonary hypertension in patients with interstitial lung disease
Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases
Year: 2011
Pulmonary rehabilitation for interstitial lung disease
Source: ERS Course 2017
Year: 2017
Pulmonary rehabilitation in interstitial lung disease
Source: ERS Course 2020 - Pulmonary rehabilitation
Year: 2020
Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
The role of secondary pulmonary hypertension (SPH) in the limited exercise tolerance of patients with interstitial lung disease (ILD)
Source: Eur Respir J 2005; 26: Suppl. 49, 560s
Year: 2005
Effects of pulmonary rehabilitation on systemic and pulmonary inflammation in COPD patients
Source: Annual Congress 2010 - Exercise in COPD
Year: 2010
Effects of pulmonary rehabilitation on systemic inflammation in patients with advanced COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 721s
Year: 2005
Pulmonary rehabilitation in interstitial lung diseases compared with chronic obstructive pulmonary disease
Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases
Year: 2019
Effect of baseline FVC on lung function decline with nintedanib in patients with IPF
Source: International Congress 2015 – Treatment of IPF
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept